SECURITIES (DISCLOSURE OF INTERESTS) DAILY SUMMARIES - (GEM)                         PRINTED: 23/09/02  PAGE:   1
                                                        DIRECTORS'/CHIEF EXECUTIVES' NOTIFICATIONS REPORT - B
                                                            (GRANTS, ASSIGNMENTS AND EXERCISES OF RIGHTS)

 STOCK NAME : SIIC Medtech                   (08018)

       Director/Chief Executive        G/E     Class                 Company Name                 Quantity       Exercise Period   Ex. Price  Consideration       Note
 ------------------------------------  --- ---------------  -------------------------------  ------------------  ---------------  ---------- ---------------  -----------
 ZHOU JIE                               E  OPT              SHANGHAI INDUSTRIAL HOLDINGS L-         1,200,000           -              -                   0             
                                                            TD                            

 LI WEI DA                              G  OPT              SIIC MEDICAL SCIENCE AND TECHN-         6,000,000    210103-200106        1.690                1             
                                                            OLOGY (GROUP) LIMITED         

                                        E  OPT              SHANGHAI INDUSTRIAL HOLDINGS L-         1,200,000           -              -                   0             
                                                            TD                            

 LU MING FANG                           G  OPT              SHANGHAI INDUSTRIAL HOLDINGS L-         1,500,000    210102-200705       10.432                1             
                                                            TD                            

                                        E  OPT              SHANGHAI INDUSTRIAL HOLDINGS L-         1,200,000           -              -                   0             
                                                            TD                            

                                                                     *****  END OF REPORT  *****

NOTE


N1      Exercise of share options